Castillon, Jorenda S.
HRN: 23-11-88 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/31/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
05/31/2023
06/06/2023
IV INFUSION
1.5gm
Q6
Psoas Abscess
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes